Navigation Links
Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results
Date:2/14/2008

e moved several compounds into phase 2 development, continued to expand our clinical development pipeline and finished the year with approximately $300 million in cash," said George Scangos, Ph.D., president and chief executive officer of Exelixis, Inc. "The rapid advancement of our pipeline has positioned 2008 to be a transformative year for the company. We have submitted ten abstracts to ASCO covering a number of compounds and trials. Importantly, we hope to present meaningful data sets for XL647, XL880 and XL184, as well as our inhibitors of the PI3 kinase and MAP kinase pathways. We also plan to initiate pivotal trials this year for XL647 for non-small cell lung cancer, XL184 for medullary thyroid cancer, and potentially XL019 for myelofibrosis. We also expect multiple opt-in decisions in 2008 from partners that will give us the opportunity to co-develop and profit-share in new compounds targeting important pathways commonly deregulated in human cancers."

Financial Outlook

For the full year 2008, we expect revenues in the range of $100.0 million to $130.0 million and operating expenses in the range of $290.0 million to $320.0 million, including stock-based compensation and other non-cash charges of approximately $20.0 million to $25.0 million. The increase in expenses is primarily related to the ongoing advancement and expansion of our development activities and corresponding increases in our general and administrative infrastructure. The Company's cash, cash equivalents, short-term and long-term marketable securities, investments held by Symphony Evolution, Inc. and restricted cash balance at the end of 2008 is expected to exceed $200.0 million.

Conference Call and Webcast

Exelixis' management will discuss the company's full year and fourth quarter 2007 financial results as well as general business updates during a conference call beginning at 2:00 p.m. PT/ 5:00 p.m. ET today, Thursday, February 14, 2008. To listen to a webcast of th
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Exelixis Announces February 14 Webcast of Its Fourth Quarter and Full Year 2007 Financial Results Conference Call
2. Exelixis Announces February 12 Webcast of Presentation at the 10th Annual BIO CEO and Investor Conference
3. Exelixis Announces January 31 Webcast of Presentation at the 2008 Wachovia Healthcare Conference
4. Exelixis Announces Senior Management Promotions
5. Exelixis Announces January 10 Webcast of Presentation at the 26th Annual JPMorgan Healthcare Conference
6. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
7. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
8. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
9. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
10. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
11. Exelixis Sells 80% Stake in Artemis to Taconic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22nd), in the scientific journal PLoS One ... the effect of serotonin on sensitivity to pain ... techniques., "Serotonin is a small molecule known to ... functions, from the control of sleep and appetite, ... neurotransmitter is also popularly thought to contribute to ...
(Date:8/22/2014)... gold particles are intensively investigated for application ... contrast agents and components in photonics and ... structures, fundamental for understanding physical and chemical ... Stanford University, USA, have demonstrated that high-resolution ... a three-dimensional structure in which all gold ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 The Global ... in-depth study on the current state of the Diabetes ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
(Date:8/22/2014)... Research and Markets has announced the addition ... Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - ... The global molecular biology enzymes market was ... to grow at a CAGR of 13.74% to reach ... reagents find applications in a large number of fields ...
Breaking Biology Technology:From happiness to pain: Understanding serotonin's function 2A breakthrough in imaging gold nanoparticles to atomic resolution by electron microscopy 2Diabetes Drugs Industry Growth Analysis in Global, China Regions Research Report Available at DeepResearchReports.com 2Diabetes Drugs Industry Growth Analysis in Global, China Regions Research Report Available at DeepResearchReports.com 3Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 2Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 3
... SPRING, Md., March 21, 2011 United Therapeutics ... that enrollment in its FREEDOM-C(2) registration trial was ... is a 16-week, multi-center, international, double-blind, randomized, placebo-controlled ... treprostinil diethanolamine (UT-15C) in pulmonary arterial hypertension (PAH) ...
... control the universe," famed fictional detective Dick Tracy predicted ... doubt the nation that leads the development of advanced ... serious leg-up on its Information Age competition. A smaller, ... is the spintronic grand prize and a key to ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced ... PKU Treatment) in an abstract (Abstract #91 , Mental ... Barbara Burton, MD at the 2011 annual American College ... which was funded by a grant from BioMarin, is ...
Cached Biology Technology:United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial 2Enhancing the magnetism 2Enhancing the magnetism 3First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 2First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 3First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 4First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 5First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 6First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 7First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU 8
(Date:8/22/2014)... first comprehensive study of captive black rhino reproduction ... the success of breeding programmes. , Researchers from ... University of Liverpool carried out a six-year study ... rhino. , Dr Katie Edwards led the research ... of Liverpool. She says: "Although some black rhinoceros ...
(Date:8/21/2014)... researchers from the University of Georgia recently published the genome ... Science . Their discovery paves the way for improved ... and industry. , Canola is grown across much of ... increasingly cultivated in Georgia. Canola oil used for cooking is ... rich supply of omega-3 fatty acids, but the plant is ...
(Date:8/21/2014)... might seem easy to ignore, but they are the ... depend upon. Humans are increasingly dependent on algae, too, ... and sink it to the bottom of the ocean. ... laboratory experiments, researchers have evidence showing that viruses infecting ... algae,s blooms, even when all else stays essentially the ...
Breaking Biology News(10 mins):Hormone analysis helps identify horny rhinos 2Canola genome sequence reveals evolutionary 'love triangle' 2Viruses take down massive algal blooms, with big implications for climate 2
... Since the human response to infection is highly ... facilitated by studying how similar processes occur in simpler ... disease, since they are easily handled, maintained and manipulated ... conserved. In addition, the small zebrafish embryo is highly ...
... National Institutes of Health (NIH) Transformative R01 Program ... Case Western Reserve University School of Medicine. The ... inborn genetic susceptibility to the development of colon ... only 42 recipients of this competitive new grant ...
... a dominant species in eastern U.S.,s forests before a blight ... returned to the landscape thanks in part to work by ... Improvement Program (UT TIP). Once used extensively for ... for humans and wildlife, and even as nutritious fodder for ...
Cached Biology News:Fish fend off invading germs with an initial response similar to the one found in people 2Prestigious $4.9 million NIH grant awarded to Case Western Reserve for colon cancer research 2Tennessee foresters helping to return chestnuts to American forests 2
... The APO-DIRECT Kit is a 2-color ... total cellular DNA to detect apoptotic cells ... instructions and reagents required for measuring apoptosis ... cells for assessing reagent performance; washing, reaction ...
The stirbar is used in the buffer tank of the Trans-Blot Plus cell to maintain uniform conductivity and temperature during electrophoretic transfer. Dimensions are 3.5 x 0.5 in....
... 111 mini IEF cell is an apparatus ... using polyacrylamide or agarose slab gels. The ... graphite electrodes, casting tray, 5 glass plates, ... polyacrylamide, 5 sample templates, and instructions. Dimensions ...
... wide range of next-generation features into a ... standard for flexible laboratory solutions. It puts ... pipetting, dilution, dispensing, and integrations into ... and flexible as it is efficient and ...
Biology Products: